Navigation Links
Genome-wide Association Studies Must Account for Ancestry
Date:12/16/2008

Ask someone where their ancestors were from and odds are that they know. Or maybe not. A new study published in Human Molecular Genetics suggests that scientists using the latest tools to scan the human genome must pay attention to ancestry when analyzing and interpreting their results.

Manhasset, NY (Vocus) December 16, 2008 -- Ask someone where their ancestors were from and odds are that they know. Or maybe not. A new study published in Human Molecular Genetics suggests that scientists using the latest tools to scan the human genome must pay attention to ancestry when analyzing and interpreting their results.

Chao Tian and Michael F. Seldin, MD, PhD, of University of California Davis, and Peter K. Gregersen, MD, of The Feinstein Institute for Medical Research, have identified allele frequency differences among ethnic groups and subgroups that can result in statistical errors in genetic studies and alter the outcome of the study.

Dr. Gregersen, head of the Feinstein’s Robert S. Boas Center for Genomics and Human Genetics, said that about half of the Caucasian people in the US who were asked where in Europe their ancestors came from did not have a clue. Dr. Gregersen collaborated with Dr. Seldin to identify a few thousand genetic markers that are powerful enough to point to the region where an individual’s ancestors once resided, a tool that is much more reliable than asking a person about his or her ancestry.

And this finding has more than just genealogical significance. In the Human Molecular Genetics paper, they showed that it is critical to account for ancestry in genome-wide association studies or the results may not be accurate. “We believe the ancestral differences should also be examined in the context of any clinical epidemiological study,” the scientists concluded.

“Until now, scientists have depended on a person’s knowledge of their ancestral roots when they study human populations to look for risk genes,” said Dr. Gregersen. “Even among racial groups there can be significant differences in the frequencies of certain genetic alleles.”

For instance, Dr. Gregersen studies rheumatoid arthritis, and in 2004 his team discovered an important risk gene called PTPN22. In the US, the disease associated variant of PTPN22 is present in about eight-to-10 percent of the population. Since the vast majority of Caucasians living in the US had ancestors who once lived in Europe, the few thousand genetic markers identified by Dr. Seldin were used to track those with European origins. They tested the DNA from hundreds of people in Europe and found that there was an enormous difference in the frequency of the risk variant for PTPN22, according to whether a person’s ancestors are from southern vs. northern Europe. In Southern Italy, for instance, only about three percent of the population had this specific PTPN22 allele. Moving north into Sweden, about 12-to-15 percent of the population carries this variant. This variant increases the risk for rheumatoid arthritis and a number of other autoimmune conditions.

With these same genetic markers in hand – so called “ancestry informative makers,” or “AIMs.” the scientists went after their US sample, asking whether these markers could be used to identify where a person’s ancestors were from – even if the subjects themselves did not know this information. Indeed, the study showed that they could.

Last month, Dr. Gregersen presented findings from their work at the American Society of Human Genetics meetings in Philadelphia. The team showed that these markers distinguish ancestry more precisely than any tool available today. The genetic information is so specific that one could look at genes from an Asian individual living in New York and tell whether their ancestors migrated from Cambodia, Japan, Korea or any other country in Asia.

Related studies have also shown that five-to-10 percent of Caucasians have evidence of mixture with populations of Asian or African descent, and Dr. Seldin’s genetic markers can identify these differences.

Going back to the PTPN22 gene, this team of investigators found that it is not a risk factor for rheumatoid arthritis in the Asian population. That means that if Asians were mixed into a genetic study on rheumatoid arthritis it could greatly skew the findings.

“When you put thousands of these markers together, you get a probability of who comes from Sweden or Southern Italy,” said Dr. Gregersen. “This information is important if anyone wants to use population studies to identify risk genes. These new genetic markers are a powerful tool. The practical consequence is that we no longer have to fully rely on a person’s self report. It will increase a scientist’s confidence that their finding is not a spurious association.”

In addition to the study in Human Molecular Genetics, the investigators published a similar study in PLoS Genetics earlier this year.

Contact:
Jamie Talan, science writer-in-residence
516-562-1232
631-682-8781 (cell)

###

Read the full story at http://www.prweb.com/releases/Feinstein_Institute/genetics/prweb1760194.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Video: Allen Institute for Brain Science Unveils Worlds First Genome-Wide Spinal Cord Atlas
2. Genome-wide association study on Parkinsons disease finds public home at NIH
3. Genomatix integrates genome-wide open chromatin from next generation sequencing
4. Genome-wide survey nets key melanoma gene
5. Researchers provide genetic associations from a genome-wide scan for cardiovascular disease traits
6. Finalists Announced for American Heart Associations Paul Bear Bryant College Football Coach of the Year Award
7. Catholic Health Association Statement on the Naming of Tom Daschle and Jeanne Lambrew to Health Leadership Positions in President-Elect Obamas Administration
8. National Medical Association Applauds Choice of Health and Human Services Secretary
9. American Lung Association Announces Support of Pickens Plan
10. The Association for the Advancement of Wound Care has Created the Wound Care Specialty Council
11. American Lung Association of Minnesota: Get a Flu Shot This Week -- Its National Vaccination Week
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genome-wide Association Studies Must Account for Ancestry
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, ... a medical article to the newly revamped Cosmetic Town journal section, ... hair transplant procedure known as Follicular Unit Extraction (FUE). , Dr. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation ... and home sensors for real-time monitoring of patients with ... nonprofit organization focused on disruptive health solutions for rare ... system to record and integrate behavioral, cognitive, physiological and ... ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: